Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302282014> ?p ?o ?g. }
- W4302282014 abstract "Background The prognostic relevance of prostate cancer (PCa) molecular subtypes remains controversial, given the presence of multiple foci with the possibility of different subtypes in the same patient. Aim To determine the clonal origin of heterogeneity in PCa and its association with disease progression, SPOP, ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes were analyzed. Methods A total of 103 samples from 20 PCa patients were analyzed; foci of adjacent non-tumor prostate tissue, HGPIN, GL3, GL4, GL5, and LN were examined to determine the presence of the TMPRSS2-ERG fusion and ERG, EZH2, NKX3.1, and SPINK-1 expression levels, using RT-PCR. Mutations in exons 6 and 7 of the SPOP gene were determined by sequencing. The presence of subtypes and molecular patterns were identified by combining all subtypes analyzed. To establish the clonal origin of multifocal PCa, molecular concordance between different foci of the same patient was determined. Association of these subtypes with histopathological groups and time to biochemical recurrence (BCR) was assessed. Results No mutation was found in SPOP in any sample. The ERG(+) subtype was the most frequent. The molecular pattern containing all four PCa subtypes was only detected in 3 samples (4%), all LN, but it was the most frequent (40%) in patients. Molecular discordance was the predominant status (55%) when all analyzed molecular characteristics were considered. It was possible to find all subtypes, starting as a preneoplastic lesion, and all but one LN molecular subtype were ERG(+) and NKX3.1 subtypes. Only the expression of the NKX3.1 gene was significantly different among the histopathological groups. No association was found between BCR time in patients and molecular subtypes or molecular concordance or between clinicopathological characteristics and molecular subtypes of ERG, EZH2, and SPINK-1. Conclusion The predominance of molecular discordance in prostatic foci per patient, which reflects the multifocal origin of PCa foci, highlights the importance of analyzing multiple samples to establish the prognostic and therapeutic relevance of molecular subtypes in a patient. All the subtypes analyzed here are of early onset, starting from preneoplastic lesions. NKX3.1 gene expression is the only molecular characteristic that shows a progression pattern by sample." @default.
- W4302282014 created "2022-10-06" @default.
- W4302282014 creator A5004943122 @default.
- W4302282014 creator A5016068291 @default.
- W4302282014 creator A5049412446 @default.
- W4302282014 creator A5054939967 @default.
- W4302282014 creator A5070647024 @default.
- W4302282014 creator A5081818714 @default.
- W4302282014 date "2022-10-05" @default.
- W4302282014 modified "2023-10-16" @default.
- W4302282014 title "Determination of <i>ERG</i> (+), <i>EZH2</i> , <i>NKX3.1</i> , and <i>SPINK‐1</i> subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer" @default.
- W4302282014 cites W1487004120 @default.
- W4302282014 cites W1538955795 @default.
- W4302282014 cites W1607198229 @default.
- W4302282014 cites W1930293314 @default.
- W4302282014 cites W1968093710 @default.
- W4302282014 cites W1982538300 @default.
- W4302282014 cites W1996487270 @default.
- W4302282014 cites W2021722704 @default.
- W4302282014 cites W2027845674 @default.
- W4302282014 cites W2030536448 @default.
- W4302282014 cites W2045732505 @default.
- W4302282014 cites W2052767567 @default.
- W4302282014 cites W2078981554 @default.
- W4302282014 cites W2094817063 @default.
- W4302282014 cites W2100024496 @default.
- W4302282014 cites W2101717678 @default.
- W4302282014 cites W2108244474 @default.
- W4302282014 cites W2121158863 @default.
- W4302282014 cites W2143841774 @default.
- W4302282014 cites W2161112598 @default.
- W4302282014 cites W2225120080 @default.
- W4302282014 cites W2263302822 @default.
- W4302282014 cites W2316138906 @default.
- W4302282014 cites W2340422569 @default.
- W4302282014 cites W2493667027 @default.
- W4302282014 cites W2747084483 @default.
- W4302282014 cites W2883457526 @default.
- W4302282014 cites W2889190934 @default.
- W4302282014 cites W3012148626 @default.
- W4302282014 cites W3215573483 @default.
- W4302282014 cites W4200030457 @default.
- W4302282014 cites W4214709940 @default.
- W4302282014 doi "https://doi.org/10.1002/cnr2.1728" @default.
- W4302282014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36199157" @default.
- W4302282014 hasPublicationYear "2022" @default.
- W4302282014 type Work @default.
- W4302282014 citedByCount "0" @default.
- W4302282014 crossrefType "journal-article" @default.
- W4302282014 hasAuthorship W4302282014A5004943122 @default.
- W4302282014 hasAuthorship W4302282014A5016068291 @default.
- W4302282014 hasAuthorship W4302282014A5049412446 @default.
- W4302282014 hasAuthorship W4302282014A5054939967 @default.
- W4302282014 hasAuthorship W4302282014A5070647024 @default.
- W4302282014 hasAuthorship W4302282014A5081818714 @default.
- W4302282014 hasBestOaLocation W43022820141 @default.
- W4302282014 hasConcept C103796816 @default.
- W4302282014 hasConcept C104317684 @default.
- W4302282014 hasConcept C111829193 @default.
- W4302282014 hasConcept C121608353 @default.
- W4302282014 hasConcept C142724271 @default.
- W4302282014 hasConcept C150194340 @default.
- W4302282014 hasConcept C160798450 @default.
- W4302282014 hasConcept C169760540 @default.
- W4302282014 hasConcept C2776235491 @default.
- W4302282014 hasConcept C2777008409 @default.
- W4302282014 hasConcept C2777093970 @default.
- W4302282014 hasConcept C2778042024 @default.
- W4302282014 hasConcept C2779134260 @default.
- W4302282014 hasConcept C2779466945 @default.
- W4302282014 hasConcept C2780192828 @default.
- W4302282014 hasConcept C3008058167 @default.
- W4302282014 hasConcept C50171091 @default.
- W4302282014 hasConcept C502942594 @default.
- W4302282014 hasConcept C524204448 @default.
- W4302282014 hasConcept C54355233 @default.
- W4302282014 hasConcept C71924100 @default.
- W4302282014 hasConcept C86803240 @default.
- W4302282014 hasConceptScore W4302282014C103796816 @default.
- W4302282014 hasConceptScore W4302282014C104317684 @default.
- W4302282014 hasConceptScore W4302282014C111829193 @default.
- W4302282014 hasConceptScore W4302282014C121608353 @default.
- W4302282014 hasConceptScore W4302282014C142724271 @default.
- W4302282014 hasConceptScore W4302282014C150194340 @default.
- W4302282014 hasConceptScore W4302282014C160798450 @default.
- W4302282014 hasConceptScore W4302282014C169760540 @default.
- W4302282014 hasConceptScore W4302282014C2776235491 @default.
- W4302282014 hasConceptScore W4302282014C2777008409 @default.
- W4302282014 hasConceptScore W4302282014C2777093970 @default.
- W4302282014 hasConceptScore W4302282014C2778042024 @default.
- W4302282014 hasConceptScore W4302282014C2779134260 @default.
- W4302282014 hasConceptScore W4302282014C2779466945 @default.
- W4302282014 hasConceptScore W4302282014C2780192828 @default.
- W4302282014 hasConceptScore W4302282014C3008058167 @default.
- W4302282014 hasConceptScore W4302282014C50171091 @default.
- W4302282014 hasConceptScore W4302282014C502942594 @default.
- W4302282014 hasConceptScore W4302282014C524204448 @default.
- W4302282014 hasConceptScore W4302282014C54355233 @default.
- W4302282014 hasConceptScore W4302282014C71924100 @default.
- W4302282014 hasConceptScore W4302282014C86803240 @default.